News Quantified

FOLD – amicus therapeutics, inc. (US:NASDAQ)

Amicus Therapeutics (FOLD) had its "sell (d-)" rating reaffirmed by Weiss Ratings.

3/29

01:37 pm

fold

Low

Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return [Yahoo! Finance]

Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And DCF Upside [Yahoo! Finance]

Pombiliti (Amicus Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, Forecasts [Yahoo! Finance]

Genomenon and Amicus Therapeutics Partner to Advance Fabry Disease Awareness and Diagnosis [Yahoo! Finance]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}